UNSPSC 51161724: Almitrine mesylate

This classification denotes a cns stimulant with the molecular formula C26H29F2N7.2CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6RY6V6XM8T, chemically known as 6-4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n'-di-2-propenyl-1,3,5-triazine-2,4-diamine dimethanesulfonate, but more generally known as almitrine mesylate, which bears US NIH Compound Identifier 6918543. European Medicines Agency schedules almitrine mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05348MIG.

UNSPSC 51161724 Almitrine mesylate, a Commodity code, nominally designates a specific pharmaceutical product, but recent state and local solicitations tagged under this code show little activity directly aligned with almitrine mesylate procurement itself. Instead, the opportunities posted under this code reflect a broader pattern of state and local health agencies and cooperative purchasing vehicles soliciting pharmacy services, pharmaceutical distribution, and drug procurement — suggesting the code may be applied inconsistently across jurisdictions or serves as a catch-all classifier for pharmaceutical-related work. The issuing bodies include county health departments (Seminole County, Florida; Hall County, Georgia), state-level health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across participating jurisdictions including Oregon). The scope of work encompasses direct medication procurement (naloxone and drug deactivation systems), on-site pharmacy services for employee and retiree health plans, direct-to-manufacturer prescription programs, and generic multi-source pharmaceutical distribution through wholesaler networks.

Recent opportunities span Florida, Georgia, Texas, Minnesota, and Oregon. Seminole County, Florida posted IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. Hall County, Georgia issued RFQ/P #47-010 on May 4, 2026, soliciting a single qualified on-site pharmacy services provider to serve approximately 3,005 employees and dependents enrolled in the county's group health plans, with sealed proposals due June 4, 2026, at 2:00 p.m. Eastern Time under an 80/20 scoring structure weighting technical qualifications at 80 percent and cost at 20 percent. The Texas HHS Commission released RFI No. HHS0017013 on April 3, 2026, gathering market intelligence on direct-to-manufacturer prescription programs prior to formal procurement. MMCAP's January 20, 2026 RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, represents a multistate cooperative purchasing vehicle serving state and local government facilities with pricing weighted at 75 percent of the evaluation score. None of these solicitations reference almitrine mesylate specifically, indicating the code assignment may reflect administrative categorization rather than actual commodity demand.